{
    "clinical_study": {
        "@rank": "97413", 
        "arm_group": [
            {
                "arm_group_label": "Nozin Nasal Sanitizer", 
                "arm_group_type": "Experimental", 
                "description": "Apply 4 rotations of swab to each nostril every four hours"
            }, 
            {
                "arm_group_label": "Saline Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the extent to which bacterial growth in the\n      nostrils by S. aureus, a common bacteria that is found in hospital environment, can be\n      reduced by NOZIN\u00ae Nasal Sanitizer\u00ae antiseptic nasal swabs during the course of a typical\n      10-hour work period in participants known to have S. aureus in their nose passages."
        }, 
        "brief_title": "Reduction of Staph Aureus Carriage by Non-Antibiotic NOZIN\u00ae Nasal Sanitizer\u00ae Antiseptic", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "S. Aureus", 
            "Nasal Sanitizer"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All healthy health care professionals between the ages of 18 and 60 years of age who\n             are regular full-time employees of the MUSC Hospital, work a 10 or 12 hour work\n             shift, and test positive for nasal vestibular S. aureus carriage within 10 days prior\n             to their scheduled study day will be eligible to participate in the study.\n\n        Exclusion Criteria:\n\n          -  Excluded from the study will be individuals exhibiting symptoms of upper respiratory\n             disease, including chronic rhinitis/sinusitis, seasonal allergies, upper respiratory\n             infection during the previous four weeks, have known allergy to citrus or soy oil, or\n             are \"smokers\".  \"Non-smokers\" will be defined as those individuals who have abstained\n             from smoking for at least one year prior to the study.  Subjects must be able and\n             agree to refrain from using prescription and non-prescription nasal spray or other\n             nasal preparations or washes from the time of their screening up to and during their\n             scheduled study day."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "387", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01861457", 
            "org_study_id": "Nozin"
        }, 
        "intervention": [
            {
                "arm_group_label": "Nozin Nasal Sanitizer", 
                "intervention_name": "Nozin Nasal Sanitizer", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Saline Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "nasal sanitizer", 
            "S. aureus", 
            "general bacteria"
        ], 
        "lastchanged_date": "May 22, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Charleston", 
                    "country": "United States", 
                    "state": "South Carolina", 
                    "zip": "29425"
                }, 
                "name": "Medical University of South Carolina"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "overall_official": {
            "affiliation": "Medical University of South Carolina- Department of Otolaryngology - Head and Neck Surgery", 
            "last_name": "Shaun A Nguyen, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "USA:MUSC IRB", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "To determine the extent to which colonization of the vestibular region of the nares by S. aureus can be reduced by a regimen of nasal topical applications during the course of typical 10-hour work day in subjects known to exhibit S. aureus nasal carriage.", 
            "measure": "Reduction in S. aureus colonization", 
            "safety_issue": "No", 
            "time_frame": "10-hour work day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01861457"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Medical University of South Carolina", 
            "investigator_full_name": "Shaun A. Nguyen", 
            "investigator_title": "Associate Professor- Department of Otolaryngology - Head and Neck Surgery", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "A secondary aim of the study will be to evaluate the consequences of S. aureus reduction on a measure of general bacterial colonization within the vestibule in each subject.", 
            "measure": "Reduction of general bacterial colonization", 
            "safety_issue": "No", 
            "time_frame": "10-hour work day"
        }, 
        "source": "Medical University of South Carolina", 
        "sponsors": {
            "collaborator": {
                "agency": "Global Life Technologies Corp.", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Medical University of South Carolina", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}